FIELD: medicine; pharmaceuticals.
SUBSTANCE: invention relates to the pharmaceutical industry and is a pharmaceutical composition for treating pain, comprising a combination of (rac)-tramadol HCl and celecoxib in neutral form, wherein molar ratio (rac)-tramadol HCl to neutral celecoxib ranges from 1:1 to 3:1, wherein the pain is thermal hyperalgesia in the postoperative pain model.
EFFECT: invention provides a synergetic effect on the treatment of thermal hyperalgesia in the postoperative pain model.
3 cl, 1 dwg, 2 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITIONS OF COCRYSTALS OF TRAMADOL AND COXIBS | 2011 |
|
RU2567843C2 |
CO-CRYSTALLINE FORMS OF TRAMADOL AND NSAID | 2009 |
|
RU2599717C2 |
CO-CRYSTALS OF TRAMADOL AND COXIBS | 2010 |
|
RU2547830C2 |
PHARMACEUTICAL COMPOSITION CONTAINING POLMACOXIB AND PREGABALIN FOR TREATMENT OF PAIN | 2019 |
|
RU2789402C1 |
PHARMACEUTICAL COMPOSITION FOR TREATING ACUTE AND CHRONIC PAIN CONTAINING POLMACOXIB AND TRAMADOL | 2018 |
|
RU2769555C2 |
INHIBITORS OF FATTY ACID AMIDE HYDROLASE | 2007 |
|
RU2492174C2 |
(R)-PIRLINDOLE AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS FOR USE IN MEDICINE | 2014 |
|
RU2695607C2 |
(S)-PIRLINDOLE AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS FOR USE IN MEDICINE | 2014 |
|
RU2695647C2 |
CYSTATHIONINE-G-LYASE (CSE) INHIBITORS | 2013 |
|
RU2640418C2 |
METHOD OF TREATING NEUROPATHIC PAIN AND ASSOCIATED WITH IT SYNDROMES | 2005 |
|
RU2433825C2 |
Authors
Dates
2019-11-29—Published
2010-10-15—Filed